Astellas Pharma (OTCMKTS:ALPMY) Earnings Information
Astellas Pharma last posted its earnings results on January 29th, 2021. The reported $0.31 earnings per share for the quarter. The company had revenue of $3.12 billion for the quarter. Astellas Pharma has generated $0.96 earnings per share over the last year and currently has a price-to-earnings ratio of 23.9. Astellas Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 13th, 2021 based off prior year's report dates.
Astellas Pharma Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Astellas Pharma (OTCMKTS:ALPMY) Earnings Estimates
Current Year EPS Consensus Estimate: $1.28 EPS
Next Year EPS Consensus Estimate: $1.52 EPS
Astellas Pharma (OTCMKTS ALPMY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)